These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 10144942)
21. FDA issues Unique Device Identification final rule. Mathias JM OR Manager; 2013 Nov; 29(11):5, 26. PubMed ID: 24298669 [No Abstract] [Full Text] [Related]
22. Glutaraldehyde. FDA holds firm on need for 45-minute soak. OR Manager; 1996 Jun; 12(6):12-3. PubMed ID: 10157852 [No Abstract] [Full Text] [Related]
23. Beyond the US submisson process. Donawa M Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536 [TBL] [Abstract][Full Text] [Related]
24. Federal regulatory action against sporicidin cold sterilizing solution. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1991 Dec; 40(50):880-1. PubMed ID: 1749372 [No Abstract] [Full Text] [Related]
25. New female condom clears FDA committee. Next for FDA review: package label and insert. AIDS Alert; 2009 Apr; 24(4):42-4. PubMed ID: 19382364 [No Abstract] [Full Text] [Related]
26. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices. Helmanis AM Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732 [No Abstract] [Full Text] [Related]
27. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet. Moberg MA; Wood JW; Dorfman HL Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682 [No Abstract] [Full Text] [Related]
29. Biotechnology and the food label: a legal perspective. Degnan FH Food Drug Law J; 2000; 55(3):301-10. PubMed ID: 11824462 [No Abstract] [Full Text] [Related]
30. It's only skin deep: FDA regulation of skin care cosmetics claims. Liang BA; Hartman KM Cornell J Law Public Policy; 1999; 8(2):249-80. PubMed ID: 11010667 [No Abstract] [Full Text] [Related]
31. Medical devices; hearing aids; technical data amendments. Direct final rule. Food and Drug Administration, HHS Fed Regist; 2008 Jun; 73(106):31358-60. PubMed ID: 18677822 [TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of glutaraldehyde-phenate (Sporicidin) used to disinfect arthroscopes. Derby B; McGucken E Orthop Nurs; 1984; 3(5):36-8. PubMed ID: 6436775 [No Abstract] [Full Text] [Related]
33. Reaction mixed on value of new FDA regulations for dialyzer relabelling. Boudreau D Nephrol News Issues; 1995 Oct; 9(10):7-8. PubMed ID: 7494593 [No Abstract] [Full Text] [Related]
34. A global view of the First Amendment constraints of FDA. Carver KH Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459 [No Abstract] [Full Text] [Related]
35. A state of extinction: does Food and Drug Administration approval of a prescription drug label extinguish state claims for inadequate warning? O'Reilly JT Food Drug Law J; 2003; 58(2):287-97. PubMed ID: 12866560 [No Abstract] [Full Text] [Related]
36. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims. Schramm MJ Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325 [No Abstract] [Full Text] [Related]
37. FDA NPRM would standardize blood labeling to permit inventory automation. McNeal BM Health Law Vigil; 1980 Dec; 3(24):6-7. PubMed ID: 10248995 [No Abstract] [Full Text] [Related]
39. Commentary: can we talk? About Food and Drug Regulation and the First Amendment. Cohen MN Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458 [No Abstract] [Full Text] [Related]
40. The Dietary Supplement Health and Education Act. Young AL; Bass IS Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]